07/29/2025- Halfjaarresultaten 2025
▪ Sales of CHF 5,676.4 million (previous year: CHF 5,834.8 million) in first half of the year
▪ 1.6% sales increase in local currencies, with 0.6% attributable to organic growth and 1.0% to acquisition effect
▪ Weaker US dollar predominantly responsible for high foreign currency impact of -4.3%
▪ Material margin at a consistently high level of 55.1% (previous year: 55.1%)
▪ EBITDA margin increased to 18.9% (previous year: 18.7%), supported by strong synergy momentum; raised MBCC synergy targets for 2025 and 2026 by CHF 20 million
Targeted investments in future growth:
▪ Strategic acquisition of Elmich (Singapore), Cromar (UK), HPS (USA), and
Gulf Additive (Qatar)
▪ Global production capacity expanded with new factories in Singapore, Xi’an and Suzhou (China), Quito (Ecuador), Ust-Kamenogorsk (Kazakhstan), Belo Horizonte (Brazil), and Agadir (Morocco)
Outlook for the 2025 business year:
▪ Amid uncertain market development, Sika will continue to grow above the market and is focusing on margin improvement
▪ Modest sales increase in local currencies expected for the full year
▪ Successful integration of MBCC – increased synergy targets for 2025 and 2026
▪ Over-proportional EBITDA increase and EBITDA margin of between 19.5% and 19.8%
▪ Strategic medium-term targets for sustainable, profitable growth confirmed for 2028
Dit fundamenteel gezond bedrijf, opgericht in 1910, met wereldwijd vestigingen (minder last van tarieven) heeft momenteel niet het momentum van de AI-spelers en ondervindt, zoals Pascal al aangaf, de mindere gang van zaken in de bouw en het effect van de dollar. De beurs loop steeds vooruit op de feiten, wanneer de zaken keren kan niemand voorspellen…en investeren aan de laagste koers lukt ook niemand, mij lijkt het interessant.